Quarterly Activities/Appendix 4C Cash Flow Report June 2026

Key points

• Company entered voluntary administration on 20 November 2024
• Deed of Company Arrangement executed on 19 March 2025
• Ended June 2026 with $10k in cash and cash equivalents
• No payments to related parties in the quarter
• No financing facilities available at quarter end

Full summary

Genetic Technologies Limited (ASX: GTG) reported its Appendix 4C and Quarterly Activities Report for the quarter ended 30 June 2026. The company had $10,000 in cash and cash equivalents at the end of June 2026. Operating cash movements during the quarter were minimal, amounting to approximately $0.1k, primarily related to residual administration and corporate costs. There were no payments to related parties or their associates during the quarter, as per ASX Listing Rule 4.7C.3. The company has no financing facilities available at the end of the quarter.